Vineet Laboratories (BOM:543298) Interest Expense : ₹-27 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Vineet Laboratories Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Vineet Laboratories's interest expense for the three months ended in Dec. 2023 was ₹ -11 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-27 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Vineet Laboratories's Operating Income for the three months ended in Dec. 2023 was ₹ -13 Mil. Vineet Laboratories's Interest Expense for the three months ended in Dec. 2023 was ₹ -11 Mil. Vineet Laboratories did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vineet Laboratories Interest Expense Historical Data

The historical data trend for Vineet Laboratories's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vineet Laboratories Interest Expense Chart

Vineet Laboratories Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Interest Expense

Get a 7-Day Free Trial

-20.55

-14.89

-26.58

Vineet Laboratories Quarterly Data
	Mar17	Mar18	Mar19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial											-10.31	3.52	-9.59	-10.25	-10.77

Vineet Laboratories Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-27 Mil.

Vineet Laboratories (BOM:543298) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vineet Laboratories's Interest Expense for the three months ended in Dec. 2023 was ₹-11 Mil. Its Operating Income for the three months ended in Dec. 2023 was ₹-13 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was ₹0 Mil.

Vineet Laboratories's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Vineet Laboratories did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Vineet Laboratories (BOM:543298) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vineet Laboratories Ltd (BOM:543298) » Definitions » Interest Expense

Traded in Other Exchanges

VINEETLAB:India

Address

5-5-160, Malleswari Nilayam, Opposite Vishnu Theatre, Chintalakunta, L.B.Nagar, Hyderabad, TG, IND, 500 074

Website

https://www.vineetlabs.co.in

Vineet Laboratories Ltd Formerly known as Ortin Laboratories Limited, Unit-II is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Isopropyl-beta-D-thiogalactopyranoside and Nitrophenyl phosphate disodium salt among others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, manufacture of Drug Intermediates & Bulk Dugs.

Vineet Laboratories (BOM:543298) Headlines

No Headlines